Heparin injection recalled as Baxter investigates


Baxter issues voluntary recall of heparin

Reported adverse events associated with Baxter's heparin sodium injection 1000 units/ml have prompted the company to recall certain lots of the product while it investigates the cause. The affected lots include both 10-ml and 30-ml vials. The 10-ml vials affected are from lots 107054 and 117085. The 30-ml vials affected include lots 047056, 097081, 107024, 107064, 107066, 107074, and 107111. A complete list of reported adverse events can be found at

Related Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.